Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
Just caught ADM's Q4 results and honestly, the earnings beat didn't really move the needle on the revenue side. They posted 87 cents adjusted EPS, which beat estimates, but that's down from $1.14 last year - so yeah, the hurt quotes are pretty real here. Revenue dropped 13.7% to $18.6 billion, missing the $22.3 billion consensus pretty badly.
The segment breakdown tells the story. Ag Services & Oilseeds took the biggest hit, down 16.9% year-over-year to $14 billion. Crush margins got absolutely wrecked - that subsegment's operating profit tanked 69%. They're blaming weaker margins in North and South America, plus some rough mark-to-market swings. Carbohydrate Solutions was flat-ish, down 6%, while Nutrition barely moved at 0.7% growth.
What caught my eye though - management's still optimistic for 2026, guiding $3.60-$4.25 adjusted EPS. They're banking on crush margins stabilizing and better trade flows. Also bumped the dividend to 52 cents per share, so they're not panicking. Stock's up 13.2% over three months, which is interesting given how rough these numbers look. Feels like the market's pricing in that recovery narrative.